Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Long-Term Debt Issuances (2016 - 2017)

Bone Biologics (BBLG) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $700000.0 as the latest value for Q3 2017.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $700000.0 in Q3 2017 year-over-year; TTM through Dec 2017 was $2.7 million, a 12.43% decrease, with the full-year FY2024 number at $1.8 million, changed N/A from a year prior.
  • Long-Term Debt Issuances was $700000.0 for Q3 2017 at Bone Biologics, down from $2.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $2.0 million in Q1 2017 to a low of $700000.0 in Q3 2017.